The Chagrin Valley Chamber of Commerce will host its 11th annual Chagrin Valley Restaurant Week, Jan. 27 to Feb. 2.

Francois Cedric, the Chief Executive Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a $3.86 billion market cap ...

The Phase Ib trial is set to test a gene therapy designed to target a rare disorder that causes muscle and respiratory failure.

Raised approximately $12.08 million in gross proceeds since beginning of December 2024 Proceeds intended to be directed for development costs to ...

Four top athlete alumni at Independence High School are to be honored by being inducted into the school’s Hall of Fame.

As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval ...

And while Wood said the pharma still isn’t interested in joining the overcrowded obesity landscape, GSK is considering ways ...

Johnson & Johnson (J&J) has agreed to pay $132 per share to acquire Intra-Cellular Therapies Inc. in a deal valued at about $14.6 billion, taking ownership of Caplyta (lumateperone), a once-daily oral ...

Entering 2025 having demonstrated rapid translation of genetic insights to positive clinical data; advancing clinically validated and multi-modal ...

Yang Zhang, Ph.D., and Jinjun Shi, Ph.D., both of the Center for Nanomedicine and Department of Anesthesiology, Perioperative ...